Garofalo Health Care S.p.A. (BIT:GHC)
Italy
· Delayed Price · Currency is EUR 5.09
-0.04 (-0.78%)
At close: Jun 26, 2025, 5:30 PM CET
Garofalo Health Care Revenue
Garofalo Health Care had revenue of 128.56M EUR in the quarter ending March 31, 2025, with 1.92% growth. This brings the company's revenue in the last twelve months to 470.20M, up 17.55% year-over-year. In the year 2024, Garofalo Health Care had annual revenue of 467.77M with 27.76% growth.
Revenue (ttm)
470.20M
Revenue Growth
+17.55%
P/S Ratio
0.96
Revenue / Employee
186.14K
Employees
2,708
Market Cap
452.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 467.77M | 101.63M | 27.76% |
| Dec 31, 2023 | 366.14M | 46.10M | 14.40% |
| Dec 31, 2022 | 320.04M | 37.12M | 13.12% |
| Dec 31, 2021 | 282.93M | 74.59M | 35.80% |
| Dec 31, 2020 | 208.34M | 13.98M | 7.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.41B |
| DiaSorin | 1.21B |
| Amplifon | 2.42B |
| Philogen | 77.65M |
| EL.En. | 577.19M |
| Pharmanutra | 116.15M |
| Safilo Group | 993.22M |
| GPI S.p.A. | 509.93M |